Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435442
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-24
Brief Title:
PKPD and DDI of Epaminurad and Naproxen in Healthy Volunteers
Sponsor:
JW Pharmaceutical
Organization:
JW Pharmaceutical
Study Overview
Official Title:
A Phase 1 Study to Evaluate the Safety and PKPD Drug-drug Interaction Between Epaminurad and Naproxen or to Assess the Safety and Multiple-Dose PKPD Characteristics of Epaminurad in Healthy Volunteers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase 1 Study to evaluate the safety PKPD drug-drug interactionDDI of Epaminurad and Naproxen in Healthy Volunteers
Detailed Description:
Part 1 to evaluate the safety PKPD drug-drug interactionDDI of Epaminurad and Naproxen in Healthy Koreans Part 2 to evaluate the safety PKPD of Epaminurad in Healthy Caucasians
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None